Form D Explorer

Aegle Therapeutics Corp research brief

CIK 1797825

Generated Nov. 19, 2026, 3:58 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: WOBURN Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

Reviewed offering links

Citation: Form D Explorer, “Aegle Therapeutics Corp research brief,” CIK 1797825, retrieved Nov. 19, 2026, 3:58 a.m.. Cite the specific accessions used. No amounts have been summed.